Taiwan's Foxconn , which rose to become a global tech manufacturing juggernaut by assembling millions of iPhones, can now say its main business is no longer Apple as it takes advantage of the AI-boom to diversify its income.
In Q2, Meta Platform's NASDAQ: META advertising business showed the market everything it wanted to see. However, Meta's Reality Labs segment continues to be an eyesore.
In the second quarter, shipments from Samsung surged in the U.S., with its market share rising from 23% to 31%, according to data from Canalys. Last month, Samsung introduced two new folding phones, one that can effectively turn into a tablet, and another that resembles an old-school flip phone with modern features.
Investors are back on the Apple (AAPL -0.55%) train. The stock of the multinational technology giant is still down slightly in 2025 but popped over 10% in the last week after management announced new planned spending in the U.S. CEO Tim Cook even visited the White House in a joint press conference with President Donald Trump to announce this new planned spending on components for the iPhone as well as other Apple products in America.
Warren Buffett's Berkshire Hathaway has filed its quarterly Form 13F filings with the Securities and Exchange Commission.
Apple on Thursday said some of its top smartwatch models are getting a redesigned blood oxygen sensing feature, sidelined for several years by a patent dispute.
The conglomerate sold Apple shares during the second quarter, though the iPhone maker remains Berkshire's largest stockholding.
Apple will bring back the blood oxygen measurement feature to some of its watch models via a software update after receiving approval from the US government amid a protracted legal dispute over the technology, it said on Thursday.
The company said it will issue a software update to restart the technology, which was caught up in a patent dispute.
Apple announced a redesigned blood oxygen feature is rolling out to some Apple Watch users. The company has been embroiled in a years-long intellectual property dispute with Masimo over the capability.